Nevoid basal cell carcinoma syndrome: Relation with desmoplastic medulloblastoma in infancy: A population-based study and review of the literature

Cancer

Volumn 98, Issue 3, 2003, Pages 618-624

  Amlashi, Seyed F A ^a   Riffaud, Laurent ^a   Brassier, Gilles ^a   Morandi, Xavier ^a  

^a PONTCHAILLOU UNIVERSITY HOSPITAL   (France)

Author keywords

Desmoplastic; Gorlin syndrome; Infancy; Medulloblastoma (MB); Nevoid basal cell carcinoma syndrome (NBCCS)

Indexed keywords

ARTICLE; BASAL CELL CARCINOMA; BASAL CELL NEVUS SYNDROME; CANCER DIAGNOSIS; CANCER RADIOTHERAPY; CANCER SUSCEPTIBILITY; CASE REPORT; CHILD; FEMALE; GENETIC COUNSELING; HISTOPATHOLOGY; HUMAN; INFANT; INTRACRANIAL TUMOR; MALE; MEDICAL RECORD; MEDULLOBLASTOMA; PRIORITY JOURNAL;

ADOLESCENT; BASAL CELL NEVUS SYNDROME; CEREBELLAR NEOPLASMS; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; MALE; MEDULLOBLASTOMA; NEOPLASM RECURRENCE, LOCAL; NEOPLASMS, RADIATION-INDUCED; POPULATION SURVEILLANCE; PROGNOSIS; RADIOTHERAPY; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 0037622972     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.11537     Document Type: Article

References (43)

1. Herzberg JJ, Wiskemann A. Die fünfte Phakomatose. Basalzellnaevus mit familiarer Belastung und Medulloblastom. Dermatologica. 1963;126:106-123.
2. Hermans EJ, Grosfield JCM, Spaas JAJ. The fifth phacomatosis. Dermatologica. 1965;130:446-476.
3. Gorlin RJ. Nevoid basal cell carcinoma (Gorlin) syndrome: unanswered issues. J Lab Clin Med. 1999;134:551-552.
4. Kimonis VE, Goldstein AM, Pastakia B, et al. Clinical manifestations in 105 persons with nevoid basal cell carcinoma syndrome. Am J Med Genet. 1997;69:299-308.
5. Cowan R, Hoban P, Kelsey A, Birch JM, Gattamaneni R, Evans DGR. The gene for the naevoid basal cell carcinoma syndrome acts as a tumour-suppressor gene in medulloblastoma. Br J Cancer. 1997;76:141-145.
6. Hahn H, Wojnowski L, Zimmer AM, et al. Mutations of the human homolog of Drosophila patched in the nevoid basal cell carcinoma syndrome. Cell. 1996;85:841-851.
7. Johnson RL, Rothman AL, Xie J, et al. Human homolog of patched, a candidate gene for the basal cell nevus syndrome. Science. 1996;272:1668-1671.
8. Farndon PA, Del Mastro RG, Evans DGR, Kilpatrick MW. Location of gene for Gorlin syndrome. Lancet. 1992;339:581-582.
9. Evans DGR, Farndon PA, Burnell LD, Rao Gattamaneni H, Birch JM. The incidence of Gorlin syndrome in 173 consecutive cases of medulloblastoma. Br J Cancer. 1991;64:959-961.
10. Strong LC. Genetic and environmental interactions. Cancer. 1977;40:1861-1866.
11. Neblett CR, Waltz TA, Anderson DE. Neurological involvement in the nevoid basal cell carcinoma syndrome. J Neurosurg. 1971;35:577-584.
12. Schofield D, West DC, Anthony DC, Marshal R, Sklar J. Correlation of loss of heterozygosity at chromosome 9q with histological subtype in medulloblastomas. Am J Pathol. 1995;146:472-480.
13. Chevrant-Breton J, Bousser AM, Aunac-Raoul M, Faivre J, Collas P, Lancien G. Naevomatose baso-cellulaire et médulloblastome. [Basal cells nevus syndrome and medulloblastoma]. Ann Dermatol Venereol. 1988;115:1115-1117.
14. Graham JK, McJimsey BA, Hardin JC. Nevoid basal cell carcinoma syndrome. Arch Otolaryngol. 1968;87:72-77.
15. Moynahan EJ. Multiple basal cell naevus syndrome - successful treatment of basal cell tumours with 5-fluorouracil. Proc R Soc Med. 1973;66:627-628.
16. Strong LC. Theories of pathogenesis: mutation and cancer. In: Mulvihill JJ, Miller RW, Fraumeni JF. The genetics of human cancer. New York: Raven Press, 1977:401-414.
17. Heimler A, Friedman E, Rosenthal AD. Naevoid basal cell carcinoma syndrome and Charcot-Marie-Tooth disease. Two autosomal dominant disorders segregating in a family. J Med Genet. 1978;15:288-291.
18. Hawkins III CJ, Hoffman HJ, Becker LE. Multiple nevoid basal-cell carcinoma syndrome (Gorlin's syndrome): possible confusion with metastatic medulloblastoma. Case report. J Neurosurg. 1979;50:100-102.
19. Southwick GJ, Schwartz RA. The basal cell nevus syndrome. Disasters occurring among a series of 36 patients. Cancer. 1979;44:2294-2305.
20. Naguib MG, Sung JH, Erickson DL, Gold LHA, Seljeskog EL. Central nervous system involvement in the nevoid basal cell carcinoma syndrome: case report and review of the literature. Neurosurgery. 1982;11:52-56.
21. Kraemer BB, Silva EG, Sneige N. Fibrosarcoma of ovary: a new component in the nevoid basal-cell carcinoma syndrome. Am J Surg Pathol. 1984;8:231-236.
22. Balsa RE, Ingratta SM, Galeano FA, Raffaeli CA, Drut R, Vestfrid M. Sindrome nevo basocelular. Presentacion de dos casos. Uno, asociado a meduloblastoma. Basal cell nevus syndrome. [Presentation of 2 cases associated with medulloblastoma]. Med Cutan Ibero Lat Am. 1985;13:5-11.
23. Pratt MD, Jackson R. Nevoid basal cell carcinoma syndrome. A 15-year follow-up of cases in Ottawa and the Ottawa valley. J Am Acad Dermatol. 1987;16:964-970.
24. Woolgar JA, Rippin JW, Taylor M, Browne RM. The basal cell naevus syndrome. Br J Hosp Med. 1987;38:344-350.
25. Lacombe D, Chateil JF, Fontan D, Battin J. Medulloblastoma in the nevoid basal-cell carcinoma syndrome: case reports and review of the literature. Genet Couns. 1990;1:273-277.
26. Romero Perez JA, Lleras Santana I. Basal cell nevus syndrome and medulloblastoma: a case report. Bol Asoc Med P R. 1993;85:24-26.
27. Albrecht S, Goodman C, Rajagopolan S, Levy M, Cech DA, Cooley LD. Malignant meningioma in Gorlin's syndrome: cytogenetic and p53 gene analysis. Case report. J Neurosurg. 1994;81:466-471.
28. Pivnick EK, Walter AW, Lawrence MD, Smith ME. Gorlin syndrome associated with midline nasal dermoid cyst. J Med Genet. 1996;33:704-706.
29. O'Malley S, Weitman D, Olding M, Sekhar L. Multiple neoplasms following craniospinal irradiation for medulloblastoma in a patient with nevoid basal cell carcinoma syndrome. Case report. J Neurosurg. 1997;86:286-288.
30. Korczak JF, Brahim JS, DiGiovanna JJ, Kase RG, Wexler LH, Goldstein AM. Nevoid basal cell carcinoma syndrome with medulloblastoma in an African-American boy: a rare case illustrating gene-environment interaction. Am J Med Genet. 1997;69:309-314.
31. Atahan IL, Yildiz F, Ozyar E, Uzal D, Zorlu F. Basal cell carcinomas developing in a case of medulloblastoma associated with Gorlin's syndrome. Pediatr Hematol Oncol. 1998;15:187-191.
32. Vortmeyer AO, Stavrou T, Selby D, et al. Deletion analysis of the adenomatous polyposis coli and PTCH gene loci in patients with sporadic and nevoid basal cell carcinoma syndrome-associated medulloblastoma. Cancer. 1999;15:2662-2667.
33. Taylor WR, Anderson DE, Howel JB, Thurston JS. The nevoid basal cell carcinoma syndrome: autopsy findings. Arch Dermatol. 1968;98:612-614.
34. Cutler TP, Holden CA, Macdonald DM. Multiple naevoid basal cell carcinoma syndrome (Gorlin's syndrome). Clin Exp Dermatol. 1979;4:373-379.
35. Evans DGR, Birch JM, Orton CI. Brain tumours and the occurrence of severe invasive basal cell carcinomata in first degree relatives with Gorlin syndrome. Br J Neurosurg. 1991;5:643-646.
36. Evans DGR, Ladusans EJ, Rimmer S, Burnell LD, Thakker N, Farndon DA. Complications of the naevoid basal cell carcinoma syndrome: results of a population based study. J Med Genet. 1993;30:460-464.
37. Walter AW, Pivnick EK, Bale AE, Kun LE. Complications of the nevoid basal cell carcinoma syndrome: a case report. J Pediatr Hematol Oncol. 1997;19:258-262.
38. Turner C, Er N, Balci S, Ataç A. Two male patients with nevoid basal cell carcinoma syndrome from Turkey. Turk J Pediatr. 2001;43:351-355.
39. Binger DD, McLendon RE, Bruner JM. Russel and Rubinstein's pathology of tumors of the nervous system. 6th edition. New York: Oxford University Press, 1998.
40. Provias JP, Becker LE. Cellular and molecular pathology of medulloblastoma. J Neurooncol. 1996;29:35-43.
41. Gorlin RJ, Sedano HO. Multiple nevoid basal cell carcinoma syndrome. In: Vinken PJ, Bruyn GW, editors. Handbook of clinical neurology. Volume 14. Amsterdam: North-Holland pc., 1972:455-473.
42. Xie J, Johnson RL, Zhang X, et al. Mutations of the Patched gene in several types of sporadic extra-cutaneous tumors. Cancer Res. 1997;57:2369-2372.
43. Hahn H, Wojnowski L, Specht K, et al. Patched target Igf2 is indispensable for the formation of medulloblastoma and rhabdomyosarcoma. J Biol Chem. 2000;37:28341-28344.